Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bronwyn Stuckey

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Epidemiology|May 4, 2019
Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
The Lancet. Diabetes & Endocrinology|December 18, 2020
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trialGary Wittert, Karen Bracken, Kristy P Robledo, et al.
Diabetes, Obesity & Metabolism|February 21, 2020
A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetesFrancois Curtin, Bernard Champion, Peter Davoren, et al.
International Journal of Epidemiology|July 11, 2013
Metabolomic markers reveal novel pathways of ageing and early development in human populationsCristina Menni, Gabriella Kastenmüller, Ann Kristin Petersen, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Epidemiology|May 4, 2019
Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
The Lancet. Diabetes & Endocrinology|December 18, 2020
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trialGary Wittert, Karen Bracken, Kristy P Robledo, et al.
Diabetes, Obesity & Metabolism|February 21, 2020
A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetesFrancois Curtin, Bernard Champion, Peter Davoren, et al.
International Journal of Epidemiology|July 11, 2013
Metabolomic markers reveal novel pathways of ageing and early development in human populationsCristina Menni, Gabriella Kastenmüller, Ann Kristin Petersen, et al.
Pageof 3